Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension.
暂无分享,去创建一个
J. Orens | M. Juhaszova | J. Conte | L. Rubin | J. X. Yuan | S. Gaine | Jian Wang | J. Wang | A. Aldinger | J. Yuan | Lewis J. Rubin | Annika Aldinger | Jason X.-J. Yuan
[1] L. Shimoda,et al. Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[2] M. Juhaszova,et al. Attenuated K+ channel gene transcription in primary pulmonary hypertension , 1998, The Lancet.
[3] L. Shimoda,et al. Inhibition of voltage-gated K+ current in rat intrapulmonary arterial myocytes by endothelin-1. , 1998, The American journal of physiology.
[4] M. Deitel. Appetite-suppressant Drugs and the Risk of Primary Pulmonary Hypertension? , 1997, Obesity surgery.
[5] J. Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension , 1997 .
[6] S. Archer,et al. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. , 1996, Circulation.
[7] M. Blaustein,et al. NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Wilke,et al. Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. , 1996, The New England journal of medicine.
[9] J. Hoidal,et al. Potassium currents in cultured human pulmonary arterial smooth muscle cells. , 1996, Journal of applied physiology.
[10] P. Pratt,et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.
[11] M. Rekhter,et al. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types. , 1995, Circulation research.
[12] X. J. Yuan,et al. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. , 1995, Circulation research.
[13] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[14] M. Berridge,et al. Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[15] M. Nelson,et al. Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.
[16] D. Clapham,et al. Calcium signaling , 1995, Cell.
[17] N. Allbritton,et al. Source of nuclear calcium signals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] B. Fleischmann,et al. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Trimmer,et al. Dexamethasone rapidly induces Kv1.5 K+ channel gene transcription and expression in clonal pituitary cells , 1993, Neuron.
[20] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[21] P. Davies,et al. Mechanical stress mechanisms and the cell. An endothelial paradigm. , 1993, Circulation research.
[22] V. S. Zhdanov,et al. [Pathology of primary pulmonary hypertension]. , 1993, Arkhiv patologii.
[23] B. Groves,et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.
[24] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[25] J. Wallwork,et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. , 1991, The New England journal of medicine.
[26] R. Virmani,et al. The pathology of primary pulmonary hypertension. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[27] J B Patlak,et al. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. , 1990, The American journal of physiology.
[28] H. Palevsky,et al. Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents. , 1989, Circulation.
[29] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[30] C. Wagenvoort,et al. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .
[31] Wagenvoort Ca. The pathology of primary pulmonary hypertension. , 1970 .
[32] P. Wood. PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR* , 1958, British heart journal.